We’ve covered the health hazards of ‘atypical’ antipsychotics, including the recent FDA warning that they increase mortality among elderly patients. But a new study has just been published that draws the same conclusion for the older, ‘conventional’...
The maverick practice of off-label prescribing - giving drugs for unapproved conditions/patients - is once again in the limelight. The US Food and Drug Administration (FDA) has issued a warning against using ‘atypical antipsychotics’ to treat...
What Doctors Don't Tell You